HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saila B Koivusalo Selected Research

Glucose (Dextrose)

3/2024Periodic Mobile Application (eMOM) With Self-Tracking of Glucose and Lifestyle Improves Treatment of Diet-Controlled Gestational Diabetes Without Human Guidance: A Randomized Controlled Trial.
11/2022Comprehensive self-tracking of blood glucose and lifestyle with a mobile application in the management of gestational diabetes: a study protocol for a randomised controlled trial (eMOM GDM study).
1/2021Ideal Cardiovascular Health and Vascular Phenotype Associations in Mothers with Obesity and Their Six-Year-Old Children.
12/2020No effect of gestational diabetes or pre-gestational obesity on 6-year offspring left ventricular function-RADIEL study follow-up.
1/2019Long-term effects of a preconception lifestyle intervention on cardiometabolic health of overweight and obese women.
5/2018Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up.
1/2018Effects of a Lifestyle Intervention During Pregnancy and First Postpartum Year: Findings From the RADIEL Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saila B Koivusalo Research Topics

Disease

9Gestational Diabetes (Gestational Diabetes Mellitus)
03/2024 - 01/2016
3Obesity
10/2021 - 01/2018
2Birth Weight (Birth Weights)
11/2023 - 11/2022
2Type 2 Diabetes Mellitus (MODY)
05/2018 - 01/2018
1Pregnancy Complications
03/2024
1Weight Gain
03/2024
1Inflammation (Inflammations)
10/2023
1Gestational Weight Gain
11/2022
1Insulin Resistance
01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2018
1Glucose Intolerance
01/2018

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
03/2024 - 01/2018
3CholesterolIBA
11/2023 - 01/2018
3high fluorescent intermediate IIIBA
10/2018 - 01/2016
2Amino AcidsFDA Link
10/2023 - 10/2021
1CarbohydratesIBA
03/2024
1Triglycerides (Triacylglycerol)IBA
11/2023
1Glycerophospholipids (Phosphoglycerides)IBA
11/2023
1Blood Glucose (Blood Sugar)IBA
11/2022
1VLDL LipoproteinsIBA
10/2021
1LipidsIBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Lipoproteins (Lipoprotein)IBA
10/2018
1oxidized low density lipoproteinIBA
10/2018
1Fatty Acids (Saturated Fatty Acids)IBA
10/2018
1hydroxide ionIBA
01/2018
125-hydroxyvitamin DIBA
01/2018
1SqualeneIBA
01/2018
1SterolsIBA
01/2018
1Melatonin Receptors (Melatonin Receptor)IBA
01/2016